Simon Fillatreau
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Simon Fillatreau has a total of 454 co-authors. Here are the top co-authors by number of shared publications:
Ping Shen
Deutsches Rheumaforschungszentrum Berlin, a Leibniz Institute Germany
17 shared publicationsVicky Lampropoulou
Deutsches Rheumaforschungszentrum Berlin, a Leibniz Institute Germany
15 shared publicationsStephen M. Anderton
University of Edinburgh Edinburgh UK
12 shared publicationsEllen Hilgenberg
Deutsches Rheumaforschungszentrum Berlin, a Leibniz Institute Germany
11 shared publicationsStefanie Ries
Deutsches Rheuma-Forschungszentrum, a Leibniz Institute, 10117 Berlin, Germany
10 shared publications- Toralf Roch
Center for Translational Medicine and Immune Diagnostics Laboratory, Medical Department I, Marien Hospital Herne, University Hospital of the Ruhr-University Bochum, Herne, Germany; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, BIH Center for Regenerative Therapies (BCRT), Berlin, Germany
10 shared publications
Latest Publications
- Open Access
- 28 September 2026
- Published by Wiley in Immunological Reviews
- Vol. 343 (1) , e70180
Building an Interleukin‐10‐Producing Identity: How B Cells Acquire Interleukin‐10 Competence and How Plasma Cell Differentiation Consolidates This Program
Interleukin (IL)‐10‐producing B cells represent an archetype for the regulatory functions of B cells. Here, we review the cell‐surface receptors and transcriptional regulators that control IL‐10 expression in B cells and enable their regulatory function in vivo. To integrate available data, we propose a three‐layer competence–execution–stabilization (CES) framework for IL‐10‐mediated B cell regulation. We propose that B cell receptor signaling during B cell development and at homeostasis contributes to establishing high IL‐10 competence in selected B cell subsets at steady state. Execution of IL‐10 expression and regulatory function then requires the integration of canonical B cell activation pathways with environmental signals and involves transcriptional programs that are largely intertwined with those controlling plasma cell differentiation. Notably, chemically induced IL‐10‐producing B cells progressively differentiate into IL‐10‐producing plasma cells and acquire homogeneous and stable IL‐10 expression. Together with LAG‐3 + CD138 hi plasma cells, these cells represent the only B cell populations described so far in which IL‐10 expression approaches population‐wide penetrance. We therefore propose that plasma cell differentiation may constitute an attractor state for stabilizing IL‐10‐producing regulatory programs. The CES framework provides a conceptual basis for investigating the diversity and regulatory functions of IL‐10‐expressing B cell states in vivo.
- 28 September 2026
- Published by Wiley in Immunological Reviews
- Vol. 343 (1) , e70180
Open AccessBuilding an Interleukin‐10‐Producing Identity: How B Cells Acquire Interleukin‐10 Competence and How Plasma Cell Differentiation Consolidates This Program
Interleukin (IL)‐10‐producing B cells represent an archetype for the regulatory functions of B cells. Here, we review the cell‐surface receptors and transcriptional regulators that control IL‐10 expression in B cells and enable their regulatory function in vivo. To integrate available data, we propose a three‐layer competence–execution–stabilization (CES) framework for IL‐10‐mediated B cell regulation. We propose that B cell receptor signaling during B cell development and at homeostasis contributes to establishing high IL‐10 competence in selected B cell subsets at steady state. Execution of IL‐10 expression and regulatory function then requires the integration of canonical B cell activation pathways with environmental signals and involves transcriptional programs that are largely intertwined with those controlling plasma cell differentiation. Notably, chemically induced IL‐10‐producing B cells progressively differentiate into IL‐10‐producing plasma cells and acquire homogeneous and stable IL‐10 expression. Together with LAG‐3 + CD138 hi plasma cells, these cells represent the only B cell populations described so far in which IL‐10 expression approaches population‐wide penetrance. We therefore propose that plasma cell differentiation may constitute an attractor state for stabilizing IL‐10‐producing regulatory programs. The CES framework provides a conceptual basis for investigating the diversity and regulatory functions of IL‐10‐expressing B cell states in vivo.
- 11 November 2025
- Published by Elsevier in Cellular Immunology
- Vol. 419, 105049
The discovery of regulatory T cells: a paradigm shift in immunology
- 11 November 2025
- Published by Elsevier in Cellular Immunology
- Vol. 419, 105049
The discovery of regulatory T cells: a paradigm shift in immunology
- Open Access
- 10 November 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-20
Distinct autoreactive CD19– plasma cell subsets accumulate in lupus-prone mice
Plasma cells (PC) participate in the pathogenesis of systemic lupus erythematosus (SLE) through sustained autoantibody and inflammatory cytokine secretion. Current PC-depleting therapies risk eliminating protective long-lived PCs, highlighting the need to identify pathogenic subsets for selective targeting. Here, using single-cell RNA sequencing, B cell receptor repertoire analysis, and genetic models, we identify disease- and organ-specific PCs in lupus-prone mice. We find a substantial expansion of autoreactive CD19 – PCs, particularly class-switched CXCR3⁺ and phosphatidylcholine-specific B-1–derived subsets, which exhibit unique gene expression profiles. We show that CD19 – PCs originate from CD19 + PCs in a unidirectional manner. Peripheral blood from SLE patients shows elevated frequencies of CD19 – PCs, implicating these cells in sustaining pathogenic activity. Our findings highlight the emergence of autoreactive CD19 – PCs as a critical feature of lupus pathogenesis in mice and underscore the need for therapeutic approaches that extend beyond CD19-targeting to improve treatment strategies in SLE.
- 10 November 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-20
Open AccessDistinct autoreactive CD19– plasma cell subsets accumulate in lupus-prone mice
Plasma cells (PC) participate in the pathogenesis of systemic lupus erythematosus (SLE) through sustained autoantibody and inflammatory cytokine secretion. Current PC-depleting therapies risk eliminating protective long-lived PCs, highlighting the need to identify pathogenic subsets for selective targeting. Here, using single-cell RNA sequencing, B cell receptor repertoire analysis, and genetic models, we identify disease- and organ-specific PCs in lupus-prone mice. We find a substantial expansion of autoreactive CD19 – PCs, particularly class-switched CXCR3⁺ and phosphatidylcholine-specific B-1–derived subsets, which exhibit unique gene expression profiles. We show that CD19 – PCs originate from CD19 + PCs in a unidirectional manner. Peripheral blood from SLE patients shows elevated frequencies of CD19 – PCs, implicating these cells in sustaining pathogenic activity. Our findings highlight the emergence of autoreactive CD19 – PCs as a critical feature of lupus pathogenesis in mice and underscore the need for therapeutic approaches that extend beyond CD19-targeting to improve treatment strategies in SLE.
- Open Access
- 1 August 2025
- Published by EDP Sciences in médecine/sciences
- Vol. 41 (8-9) , 631-634
Après une infection par le virus SARS-CoV-2, les enfants d’âge préscolaire gardent une mémoire immunitaire différente de celle des individus plus âgés
Médecine/sciences (M/S), revue internationale dans le domaine de la recherche biologique, médicale et en santé
- 1 August 2025
- Published by EDP Sciences in médecine/sciences
- Vol. 41 (8-9) , 631-634
Open AccessAprès une infection par le virus SARS-CoV-2, les enfants d’âge préscolaire gardent une mémoire immunitaire différente de celle des individus plus âgés
Médecine/sciences (M/S), revue internationale dans le domaine de la recherche biologique, médicale et en santé
- 19 April 2025
- Published by Wiley in European Journal of Immunology
- Vol. 55 (4) , e202451509
Human IL‐6‐Producing B Cells Promote the Differentiation of Monocytes Toward an Anti‐Inflammatory CD16⁺CD163⁺CD206⁺PD‐L1⁺ Phenotype in Tuberculosis
The polarization of the monocyte/macrophage compartment toward an anti‐inflammatory profile is considered detrimental in tuberculosis (TB), but the factors controlling M2 polarization in this context are still poorly understood. Here, we found that B cells promote the differentiation of human monocytes toward an M2‐like activation program through a process primarily dependent on IL‐6 and the activation of STAT3 signaling in monocytes. This confers monocytes with immunomodulatory properties characterized by a reduced ability to produce proinflammatory cytokines and to stimulate IFNγ secretion by allogeneic T cells. Our findings were validated using B cells from TB patients, which constitutively produce high levels of IL‐6, underscoring the clinical relevance of our experimental observations. Collectively, our results indicate that human B‐cell‐derived IL‐6 might impair TB immunity by driving monocyte polarization toward an anti‐inflammatory phenotype.
- 19 April 2025
- Published by Wiley in European Journal of Immunology
- Vol. 55 (4) , e202451509
Human IL‐6‐Producing B Cells Promote the Differentiation of Monocytes Toward an Anti‐Inflammatory CD16⁺CD163⁺CD206⁺PD‐L1⁺ Phenotype in Tuberculosis
The polarization of the monocyte/macrophage compartment toward an anti‐inflammatory profile is considered detrimental in tuberculosis (TB), but the factors controlling M2 polarization in this context are still poorly understood. Here, we found that B cells promote the differentiation of human monocytes toward an M2‐like activation program through a process primarily dependent on IL‐6 and the activation of STAT3 signaling in monocytes. This confers monocytes with immunomodulatory properties characterized by a reduced ability to produce proinflammatory cytokines and to stimulate IFNγ secretion by allogeneic T cells. Our findings were validated using B cells from TB patients, which constitutively produce high levels of IL‐6, underscoring the clinical relevance of our experimental observations. Collectively, our results indicate that human B‐cell‐derived IL‐6 might impair TB immunity by driving monocyte polarization toward an anti‐inflammatory phenotype.
- 24 March 2025
- Published by Elsevier in Cellular Immunology
- Vol. 411-412, 104945
Immunity in children: How does it begin?
- 24 March 2025
- Published by Elsevier in Cellular Immunology
- Vol. 411-412, 104945
Immunity in children: How does it begin?
- Open Access
- 2 December 2024
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 135 (3)
Cathelicidin antimicrobial peptide expression in neutrophils and neurons antagonistically modulates neuroinflammation
Multiple sclerosis (MS) is an autoimmune disease that affects the CNS, the pathophysiology of which remains unclear and for which there is no definitive cure. Antimicrobial peptides (AMPs) are immunomodulatory molecules expressed in various tissues, including the CNS. Here, we investigated whether the cathelicidin-related AMP (CRAMP) modulated the development of experimental autoimmune encephalomyelitis (EAE), a mouse model of MS. We showed that, at an early stage, CNS-recruited neutrophils produced neutrophil extracellular traps (NETs) rich in CRAMP that were required for EAE initiation. NET-associated CRAMP stimulated IL-6 production by dendritic cells via the cGAS/STING pathway, thereby promoting encephalitogenic Th17 response. However, at a later disease stage, neurons also expressed CRAMP that reduced EAE severity. Camp knockdown in neurons led to disease exacerbation, while local injection of CRAMP 1–39 at the peak of EAE promoted disease remission. In vitro, CRAMP 1–39 regulated the activation of microglia and astrocytes through the formyl peptide receptor (FPR) 2. Finally, administration of butyrate, a gut microbiota-derived metabolite, stimulated the expression of neural CRAMP via the free fatty acids receptors 2/3 (FFAR2/3), and prevented EAE. This study shows that CRAMP produced by different cell types has opposing effects on neuroinflammation, offering therapeutic opportunities for MS and other neuroinflammatory disorders.
- 2 December 2024
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 135 (3)
Open AccessCathelicidin antimicrobial peptide expression in neutrophils and neurons antagonistically modulates neuroinflammation
Multiple sclerosis (MS) is an autoimmune disease that affects the CNS, the pathophysiology of which remains unclear and for which there is no definitive cure. Antimicrobial peptides (AMPs) are immunomodulatory molecules expressed in various tissues, including the CNS. Here, we investigated whether the cathelicidin-related AMP (CRAMP) modulated the development of experimental autoimmune encephalomyelitis (EAE), a mouse model of MS. We showed that, at an early stage, CNS-recruited neutrophils produced neutrophil extracellular traps (NETs) rich in CRAMP that were required for EAE initiation. NET-associated CRAMP stimulated IL-6 production by dendritic cells via the cGAS/STING pathway, thereby promoting encephalitogenic Th17 response. However, at a later disease stage, neurons also expressed CRAMP that reduced EAE severity. Camp knockdown in neurons led to disease exacerbation, while local injection of CRAMP 1–39 at the peak of EAE promoted disease remission. In vitro, CRAMP 1–39 regulated the activation of microglia and astrocytes through the formyl peptide receptor (FPR) 2. Finally, administration of butyrate, a gut microbiota-derived metabolite, stimulated the expression of neural CRAMP via the free fatty acids receptors 2/3 (FFAR2/3), and prevented EAE. This study shows that CRAMP produced by different cell types has opposing effects on neuroinflammation, offering therapeutic opportunities for MS and other neuroinflammatory disorders.
- 18 September 2024
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 16 (765) , eadl1997
Preschool-age children maintain a distinct memory CD4 + T cell and memory B cell response after SARS-CoV-2 infection
The development of the human immune system lasts for several years after birth. The impact of this maturation phase on the quality of adaptive immunity and the acquisition of immunological memory after infection at a young age remains incompletely defined. Here, using an antigen-reactive T cell (ARTE) assay and multidimensional flow cytometry, we profiled circulating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)–reactive CD3 + CD4 + CD154 + T cells in children and adults before infection, during infection, and 11 months after infection, stratifying children into separate age groups and adults according to disease severity. During SARS-CoV-2 infection, children younger than 5 years old displayed a lower antiviral CD4 + T cell response, whereas children older than 5 years and adults with mild disease had, quantitatively and phenotypically, comparable virus-reactive CD4 + T cell responses. Adults with severe disease mounted a response characterized by higher frequencies of virus-reactive proinflammatory and cytotoxic T cells. After SARS-CoV-2 infection, preschool-age children not only maintained neutralizing SARS-CoV-2–reactive antibodies postinfection comparable to adults but also had phenotypically distinct memory T cells displaying high inflammatory features and properties associated with migration toward inflamed sites. Moreover, preschool-age children had markedly fewer circulating virus-reactive memory B cells compared with the other cohorts. Collectively, our results reveal unique facets of antiviral immunity in humans at a young age and indicate that the maturation of adaptive responses against SARS-CoV-2 toward an adult-like profile occurs in a progressive manner.
- 18 September 2024
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 16 (765) , eadl1997
Preschool-age children maintain a distinct memory CD4 + T cell and memory B cell response after SARS-CoV-2 infection
The development of the human immune system lasts for several years after birth. The impact of this maturation phase on the quality of adaptive immunity and the acquisition of immunological memory after infection at a young age remains incompletely defined. Here, using an antigen-reactive T cell (ARTE) assay and multidimensional flow cytometry, we profiled circulating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)–reactive CD3 + CD4 + CD154 + T cells in children and adults before infection, during infection, and 11 months after infection, stratifying children into separate age groups and adults according to disease severity. During SARS-CoV-2 infection, children younger than 5 years old displayed a lower antiviral CD4 + T cell response, whereas children older than 5 years and adults with mild disease had, quantitatively and phenotypically, comparable virus-reactive CD4 + T cell responses. Adults with severe disease mounted a response characterized by higher frequencies of virus-reactive proinflammatory and cytotoxic T cells. After SARS-CoV-2 infection, preschool-age children not only maintained neutralizing SARS-CoV-2–reactive antibodies postinfection comparable to adults but also had phenotypically distinct memory T cells displaying high inflammatory features and properties associated with migration toward inflamed sites. Moreover, preschool-age children had markedly fewer circulating virus-reactive memory B cells compared with the other cohorts. Collectively, our results reveal unique facets of antiviral immunity in humans at a young age and indicate that the maturation of adaptive responses against SARS-CoV-2 toward an adult-like profile occurs in a progressive manner.
- Open Access
- 14 April 2023
- Published by Elsevier in Cell Reports
- Vol. 42 (4) , 112378
AKT activity orchestrates marginal zone B cell development in mice and humans
- 14 April 2023
- Published by Elsevier in Cell Reports
- Vol. 42 (4) , 112378
Open AccessAKT activity orchestrates marginal zone B cell development in mice and humans